AstraZeneca
AZN
#52
Rank
NZ$482.67 B
Marketcap
NZ$311.23
Share price
-1.47%
Change (1 day)
36.51%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: NZ$482.67 Billion

As of May 2026 AstraZeneca has a market cap of NZ$482.67 Billion. This makes AstraZeneca the world's 52th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$482.67 B-2.9%
2025NZ$497.06 B37.68%
2024NZ$361.02 B9.15%
2023NZ$330.76 B-0.18%
2022NZ$331.37 B24.73%
2021NZ$265.67 B46.35%
2020NZ$181.53 B-6.58%
2019NZ$194.32 B38.05%
2018NZ$140.76 B14.74%
2017NZ$122.67 B23.22%
2016NZ$99.56 B-21.19%
2015NZ$126.32 B10.51%
2014NZ$114.30 B26.76%
2013NZ$90.17 B26.54%
2012NZ$71.25 B-8.12%
2011NZ$77.55 B-8.06%
2010NZ$84.36 B-10.04%
2009NZ$93.77 B-8.37%
2008NZ$102.34 B25.65%
2007NZ$81.44 B-30.05%
2006NZ$116.44 B1.97%
2005NZ$114.19 B36.2%
2004NZ$83.84 B-33.46%
2003NZ$126.00 B9.34%
2002NZ$115.23 B-41.17%
2001NZ$195.86 B-4.57%
2000NZ$205.23 B44.65%
1999NZ$141.88 B75.41%
1998NZ$80.88 B37.38%
1997NZ$58.87 B56.84%
1996NZ$37.54 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of AstraZeneca was reported to be:

NZ$979.67 Billion
by Nasdaq info icon info icon
NZ$489.87 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$934.88 B 93.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$480.87 B-0.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$246.95 B-48.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$248.83 B-48.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.510 T 212.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$172.75 B-64.21%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$47.54 B-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$471.32 B-2.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$195.07 B-59.58%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$172.14 B-64.34%๐Ÿ‡ฌ๐Ÿ‡ง UK